ArticleCardiovascular diabetology2022

Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis.

Rongjun Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.